RE

Remedent IncOOTC REMI Stock Report

Last reporting period 31 Dec, 2020

Updated —

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

REMI Stock Analysis

RE

Uncovered

Remedent Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

22/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

20 B

Remedent, Inc. engages in the research, development, and manufacturing of oral care and cosmetic dentistry products. The company is headquartered in Ghent, Oost-Vlaanderen. The company went IPO on 2001-09-20. The firm designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The firm's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The firm offers over-the-counter (OTC) tooth whitening products. The company has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The firm has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The firm's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.

View Section: Eyestock Rating